B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Loss of Function of KMT2D in Kabuki Syndrome

REACTOME PATHWAY
Reactome: R-HSA-99449714 genes1 compounds

The Loss of Function of KMT2D in Kabuki Syndrome pathway (Reactome ID: R-HSA-9944971) involves 4 genes and is affected by 1 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ASH2LDPY30RBBP5WDR5

Compounds Affecting Loss of Function of KMT2D in Kabuki Syndrome

#CompoundTargets HitStudies
1s adenosylhomocysteine—300

About the Loss of Function of KMT2D in Kabuki Syndrome Pathway

The Loss of Function of KMT2D in Kabuki Syndrome pathway is catalogued in Reactome (ID: R-HSA-9944971) and involves 4 genes. In the BiohacksAI corpus, 1 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ASH2L, DPY30, RBBP5, WDR5.